Showing results (81-90 of 128) with videos related to
Sort By:
Pageof 13
Molecular Cell|February 8, 2005
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic functionLin Chen, Simon N Willis, Andrew Wei, et al.Neurology|August 8, 2013
Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosisLuis Querol, Pamela L Clark, Mary A Bailey, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|July 11, 2023
Extra-mandibular Osteoradionecrosis after the Treatment of Head and Neck CancerP D E Kovarik, R Patil, J Cvek, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2014
Transcription factor IRF4 regulates germinal center cell formation through a B cell-intrinsic mechanismSimon N Willis, Kim L Good-Jacobson, Joan Curtis, et al.Journal of Neuroimmunology|March 1, 2011
Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulinBirgit Obermeier, Laura Lovato, Reinhard Mentele, et al.Journal of Neuroimmunology|July 27, 2010
A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosisA J Ligocki, L Lovato, D Xiang, et al.Brain : a Journal of Neurology|July 30, 2009
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brainSimon N Willis, Christine Stadelmann, Scott J Rodig, et al.Cell and Tissue Research|November 12, 2016
Nuclear localization signal sequence is required for VACM-1/CUL5-dependent regulation of cellular growthAngelica N Willis, Shirley E Bradley Dean, Joe A Habbouche, et al.Virology|May 18, 2000
The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virusT A Martino, M Petric, H Weingartl, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|February 17, 2026
High Incidence of Mandibular Osteoradionecrosis After Radiotherapy for Oral Cavity: Time for Rebalancing Risks and BenefitsP D Kovarik, M S Iqbal, Z Davidson, et al.Pageof 13